Patients, providers, and healthcare processes benefit from systematically collecting patient-reported outcomes and reviews of their experiences in breast cancer treatment.
Immunotherapy responses may not be equal between the sexes.
Conversion of tryptophan to kynurenine was associated with lower survival rates.
The epigenetic signals in circulating cell-free DNA (cfDNA) in patients diagnosed with diffuse large B-cell lymphoma (DLBCL) could predict which cases are the most likely to recur.
The results of this new study could also further explain the patterns of tumor development among certain ethnicities.
Tucatinib showed improvements in survival in patients with HER2-positive breast cancer.
The approval comes one day after the FDA approved niraparib for the same subset of ovarian cancer.
Niraparib was approved by the (FDA) for previously treated advanced ovarian, fallopian, or primary peritoneal cancers.
Radiologists and data scientists decided to get together to evaluate the effectiveness of artificial intelligence and human observation when it comes to detecting breast cancer in mammograms.
Alcohol has been labeled a carcinogen by a growing number of agencies across the globe, after years of scientific and policy debate. But just how much of the cancer burden is it responsible for?